At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
Tolcaponedrug
Likely dose
Tolcapone 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tolcapone Treatment of Pathological Gambling: An Open-Label Study
In Brief
A Phase 2 clinical trial evaluating Tolcapone for Pathological Gambling. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The goal of the proposed study is to evaluate the efficacy and safety of tolcapone in pathological gambling.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPathological Gambling
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJun 2009
Primary CompletionMay 2012
Study CompletionJul 2012
TodayJul 2026
First PostedJun 25, 2009
Enrollment StartJun 1, 2009
Primary CompletionMay 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.0 years ago
Interventions
Tolcaponedrug
pill, 100-300mg/day for 8 weeks